Marinus Pharma (MRNS) Tops Q2 EPS by 4c

Marinus Pharma (NASDAQ: MRNS) reported Q2 EPS of ($0.65), $0.04 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $1.91 million versus the consensus estimate of $2.7 million.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Citi upgrades Bath & Body Works to Buy with $25 price target
• XP Inc. (XP) Tops Q2 EPS by 8c